Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells Through Downregulation of Akt
Journal of Cancer - Australia
doi 10.7150/jca.2.435
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2011
Authors
Publisher
Ivyspring International Publisher